Introduction
The corpus luteum of the ovary develops from a follicle after ovulation of an oocyte. Corpora lutea primarily produce the steroid hormone progesterone that is essential for the establishment and maintenance of pregnancy. If the ovulated oocyte is not fertilized and pregnancy does not occur, the corpus luteum ceases hormone production in a process known as functional luteal regression. It then undergoes structural luteal regression, characterized by cell death and the loss of luteal tissue.
In a non-fertile cycle the corpus luteum undergoes regression after a fixed species-specific period of time. This suggests that luteal cell death is programmed, and a number of studies have shown that luteal regression is associated with an increase in apoptosis (Orlicky et al, 1992; Juengel et al., 1993; Dharmarajan et al, 1994; Kenny et al, 1994; Zheng et al, 1994; Rueda et al, 1995; Young et al, 1997) .
Ubiquitin is a highly conserved 76 amino acid polypeptide that covalently conjugates to cytoplasmic proteins and marks them for subsequent proteolytic degradation. Ubiquitin also binds to histones and may regulate chromatin structure during transcription (Hershko, 1988) and thus has been immunochemically detected in both the cytoplasm and the nucleus (Haas and Bright, 1985) . Ubiquitin upregulation has been associated with apoptosis: in the tobacco hawkmoth, Manduca sexta, the developmentally programmed cell death of intersegmental muscles is associated with a tenfold increase in ubiquitin (Haas et al, 1996;  Myer and Schwartz, 1996) ; the colonial sea squirt, Botryullus schlossert, undergoes a cyclical cell death process characterized by apoptosis and upregulation of cytoplasmic ubiquitin immunoreactivity (Lauzon et al, 1993) ; and murine myoblasts committed to apoptosis show increased expression of ubiquitin (Sandri et al, 1997) . Ubiquitin mRNA is upregulated and nuclear proteins are ubiquinated in human lymphocytes induced to undergo apoptosis (Delie et al, 1993 (Summers et al, 1985; Fraser et al, 1995) or GnRH antagonist 9 days after ovulation (Hodges et al, 1988) . Functional regression is complete and structural regression is well advanced 24 h after treatment (on day 10 of the luteal phase).
The aims of this study were: (i) to examine the expression of ubiquitin in the corpora lutea of marmoset monkeys after induced luteolysis; (ii) (Fig. 1, lane 1) , but apoptotic DNA fragmentation was absent from three other midluteal phase animals (results for two animals are shown in Fig. 1, lanes 2 and 3) . Oligonucleosome fragmentation was present in all animals after induced regression with either GnRH antagonist (Fig. 1, lanes 4 and 5) or PGF2a (Fig. 1 (Fig. 3) (Figs 2c and 3) . Ubiquitin immunoreactivity was not observed after induction of luteolysis with GnRH antagonist (Fig. 2d) , nor was it found in negative control sections (Fig. 2b) (1996) reported an increase in luteal ubiquitin mRNA and protein as rapidly as 2 h after administration of a luteolytic dose of PGF2a to ewes. This observation suggests that ubiquitin is involved in functional luteal regression, since structural regression, as measured by total luteal mass, did not begin until at least 16 h after administration of PGF2a in this study. However, this does not preclude ubiquitin from involvement in structural regression. Ubiquitin immunoreactivity was not found in any animal subjected to GnRH antagonist-induced luteolysis. These data suggest that ubiquitin was not involved in structural regression in GnRH antagonist-treated animals, although it is possible that ubiquitin expression occurred earlier and was involved Fig. 1 . Autoradiograph of 3'-labelled DNA from marmoset corpora lutea subjected to electrophoresis on a 2% agarose gel. Lanes 1-3, midluteal phase controls; lanes 4 and 5, GnRH antagonist administered in vivo on day 9 of the luteal phase; lanes 6 and 7, PGF2n administered in vivo on day 9 of the luteal phase. All corpora lutea were collected on day 10 of the luteal phase. Lower lanes show negative control liver samples corresponding to the animal in the lane above. Molecular weight markers are shown on the right hand side.
in functional luteal regression. Therefore, ubiquitin expression in luteal cells may be a response to prostaglandin because only cells with prostaglandin receptors expressed ubiquitin in ovine corpora lutea (Murdoch et al, 1996) . Furthermore, luteal ubiquitin expression may not be specific for luteolysis but forms part of a response to cellular stress in which ubiquitin is coexpressed with heat shock protein 70 (Murdoch et al, 1996) , which is upregulated after PGF,ainduced regression in rats (Khanna et al, 1995) .
Apoptosis has been shown to occur during structural luteolysis (Murdoch, 1995 (Juengel et al, 1993; Rueda et al., 1995) , ovine (Kennny et al., 1994) , and rabbit (Dharmarajan et al, 1984) Ovaries were collected on day 10 of the luteal phase from control animals (n = 3) and from animals treated 24 h previously with a PGF2o analogue (n = 3). Asterisk indicates value is significantly different (P < 0.02) from corresponding midluteal phase control.
Ubiquitin has been shown to be upregulated during apoptosis in a number of systems (Delie et al, 1993; Lauzon et al, 1993; Haas et al., 1996; Myer and Schwartz, 1996; Sandri et al, 1997 
